It was found that some anti-inflammatory drugs are capable of reducing the progression of diabetes, namely salicylates and aspirin, because they can inhibit the NF-kB pathway via its ability to improve glucose metabolism and diabetes [38,39]. The gene discussed is NFKB1; the disease is diabetes mellitus.